Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Chinese Solid Tumor Patients With Taxanes-induced Painful Peripheral Neuropathy
NCT04970121Phase 2Recruiting
- Start
- Aug 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of duloxetine in chemotherapy-induced peripheral neuropathy (CIPN) and pain. Primary endpoint: Pain Score. Started Aug 2021; status: recruiting.
02
Drugs
duloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)pain
Beyond the preview
Go deeper on NCT04970121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04970121.